BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Armuzzi A, Liguori G. Quality of life in patients with moderate to severe ulcerative colitis and the impact of treatment: A narrative review. Dig Liver Dis 2021;53:803-8. [PMID: 33744172 DOI: 10.1016/j.dld.2021.03.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Feng D, Zeng Y, Zhang H, Du X, Fu Y, Wang X, Lian D, Wang R, Xiao H, Wei N, Zhai F, Liu H. Xuedan Sustained Release Pellets Ameliorate Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats by Targeting Gut Microbiota and MAPK Signaling Pathways. Front Pharmacol 2022;13:833972. [PMID: 35652042 DOI: 10.3389/fphar.2022.833972] [Reference Citation Analysis]
2 Sah J, Teeple A, Muser E, Gutierrez C, Dassopoulos T. Treatment persistence and maintenance dose titration among ulcerative colitis on biologics: a pooled study of three United States claim databases. Curr Med Res Opin 2022;:1-25. [PMID: 35475385 DOI: 10.1080/03007995.2022.2071041] [Reference Citation Analysis]
3 Nag A, Romero B. Development and content validation of patient-reported outcomes tools for ulcerative colitis and Crohn's disease in adults with moderate-to-severe disease. Health Qual Life Outcomes 2022;20:75. [PMID: 35525935 DOI: 10.1186/s12955-022-01975-1] [Reference Citation Analysis]
4 Yen H, Hsu Y, Kuo C, Hsu T, Chen Y. Real‐world experience of adalimumab therapy for patients with ulcerative colitis: A single tertiary medical center experience in Central Taiwan. Adv in Digestive Medicine. [DOI: 10.1002/aid2.13300] [Reference Citation Analysis]
5 Feng S, Sui M, Wang D, Ritzoulis C, Farag MA, Shao P. Pectin-zein based stigmasterol nanodispersions ameliorate dextran sulfate sodium-induced colitis in mice. Food Funct 2021;12:11656-70. [PMID: 34726217 DOI: 10.1039/d1fo02493k] [Reference Citation Analysis]
6 . Stellungnahme der DGVS zur Nutzenbewertung des GBA zum Wirkstoff Filgotinib (Anwendungsgebiet: Colitis Ulcerosa, vorbehandelte Patient*innen). Z Gastroenterol 2022;60:1047-50. [DOI: 10.1055/a-1851-7777] [Reference Citation Analysis]
7 Choi D, Stewart AP, Bhat S. Ozanimod: A First-in-Class Sphingosine 1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis. Ann Pharmacother 2021;:10600280211041907. [PMID: 34423657 DOI: 10.1177/10600280211041907] [Reference Citation Analysis]
8 Huang J, Zhang J, Wang Y, Ma J, Yang X, Guo X, Lv M, Ma J, Zheng Y, Wang F, Tang X, Pandurangan A. Science Evidence of Chinese Herbal Medicine (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis. Gastroenterology Research and Practice 2022;2022:1-8. [DOI: 10.1155/2022/7942845] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Miao ST, Lu QS, Zhou YJ, Chang YN, Xu T, Zhu MY. Oral administration of octacosanol modulates the gut bacteria and protects the intestinal barrier in ulcerative colitis mice. J Food Biochem 2022;:e14284. [PMID: 35746852 DOI: 10.1111/jfbc.14284] [Reference Citation Analysis]